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Highlights 18 
 Feline antibodies against cryptic Aspergillus spp. cross react with an aspergillin 19 
containing A. fumigatus antigens. 20 
 Brachycephalic cats are prone to upper respiratory tract aspergillosis (URTA). 21 
 The agar gel immunodiffusion (AGID) assay has low sensitivity for diagnosis of 22 
URTA. 23 
 IgG ELISA has high sensitivity and specificity for diagnosis of URTA. 24 
 This study provides evidence that cats with URTA are systemically 25 
immunocompetent. 26 
27 
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Abstract 28 
Feline upper respiratory tract aspergillosis (URTA) is an emerging infectious disease. 29 
The aims of this study were: (1) to assess the diagnostic value of detection of Aspergillus-30 
specific antibodies using an agar gel double immunodiffusion (AGID) assay and an indirect 31 
immunoglobulin G (IgG) ELISA; and (2) to determine if an aspergillin derived from mycelia 32 
of Aspergillus fumigatus, Aspergillus niger and Aspergillus flavus can be used to detect serum 33 
antibodies against ‘cryptic’ Aspergillus spp. in Aspergillus section Fumigati. Sera from cats 34 
with URTA (group 1: n = 21) and two control groups (group 2: cats with other upper 35 
respiratory tract diseases, n = 25; group 3: healthy cats and cats with non-respiratory, non-36 
fungal illness, n = 84) were tested. Isolates from cats with URTA comprised A. fumigatus (n = 37 
5), A. flavus (n = 1) and four cryptic species: Aspergillus felis (n = 12), Aspergillus 38 
thermomutatus (Neosartorya pseudofischeri, n = 1), Aspergillus lentulus (n = 1) and 39 
Aspergillus udagawae (n = 1). 40 
 41 
Brachycephalic purebred cats were significantly more likely to develop URTA than 42 
other breeds (P <0.013). The sensitivity (Se) of the AGID was 43% and the specificity (Sp) 43 
was 100%. At a cut-off value of 6 ELISA units/mL, the Se of the IgG ELISA was 95.2% and 44 
the Sp was 92% and 92.9% for groups 2 and 3 cats, respectively. Aspergillus-specific 45 
antibodies against all four cryptic species were detected in one or both assays. Assay Se was 46 
not associated with species identity. Detection of Aspergillus-specific antibodies by IgG 47 
ELISA has high Se and Sp for diagnosis of feline URTA. 48 
 49 
Keywords: Aspergillosis; Aspergillus spp.; Sino-nasal; Sino-orbital; Feline 50 
51 
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Introduction 52 
Feline upper respiratory tract aspergillosis (URTA) is increasingly being recognised 53 
(Barrs and Talbot, 2014). There are two anatomical forms of disease, sino-nasal aspergillosis 54 
(SNA) and sino-orbital aspergillosis (SOA) (Barrs et al., 2012, 2014). A strong association 55 
has been identified between the infecting fungal species and the anatomical form of disease; 56 
SNA is most commonly caused by Aspergillus fumigatus, while Aspergillus felis, a recently 57 
discovered ‘cryptic’ species in Aspergillus section Fumigati (Aspergillus viridinutans 58 
complex), is the most common cause of SOA (Barrs et al., 2013, 2014; Barrs and Talbot, 59 
2014). So-called cryptic species are indistinguishable on morphological features from A. 60 
fumigatus sensu stricto. 61 
 62 
Similar to SNA in dogs, feline SNA is usually non-invasive, such that fungal hyphae 63 
do not penetrate the respiratory mucosa (Whitney et al., 2005); in contrast, in SOA fungal 64 
hyphae invade sino-nasal and paranasal tissues. Invasive mycoses typically occur in 65 
immunocompromised hosts. However, systemic immunodeficiency has not been detected in 66 
most cats with URTA (Barrs et al., 2012), one exception being a cat with feline leukaemia 67 
virus (FeLV) infection (Goodall et al., 1984). 68 
 69 
The sensitivity (Se) of serological tests for detection of fungal antigens or Aspergillus-70 
specific antibodies in aspergillosis depends on the systemic immunocompetence of the host as 71 
reflected by the ability to clear fungal antigen from the circulation and to mount an antibody 72 
response. An ELISA to detect a fungal cell wall antigen, galactomannan (GM), in serum 73 
(Platelia Aspergillus EIA, Bio-Rad) has a Se of up to 90% in immunocompromised patients, 74 
including neutropenic human patients with pulmonary aspergillosis and dogs with 75 
disseminated invasive aspergillosis (DIA) (Maertens et al., 1999; Garcia et al., 2012). 76 
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However, the Se of this test is <30% in non-neutropenic human patients with aspergillosis, in 77 
immunocompetent dogs with SNA and in cats with URTA (Billen et al., 2009; Kitasato et al., 78 
2009; Whitney et al., 2013). 79 
 80 
Conversely, detection of serum Aspergillus-specific antibodies by agar gel double 81 
immunodiffusion (AGID) or by immunoglobulin G (IgG) ELISA has a high test Se in 82 
immunocompetent patients, including dogs with SNA (67-88%) and humans with chronic 83 
pulmonary aspergillosis (74-94%) (Pomrantz et al., 2007; Billen et al., 2009; Guitard et al., 84 
2012; Ohba et al., 2012). A detectable antibody response is mounted in <30% of neutropenic 85 
humans with aspergillosis and dogs with DIA (Day et al., 1985; Hope et al., 2005; Schultz et 86 
al., 2008). 87 
 88 
We hypothesised that Aspergillus-specific antibodies would be detectable in the 89 
majority of cats with URTA, since most cats with URTA are not, as far as it is possible to 90 
currently evaluate, systemically immunocompromised. The aims of this study were: (1) to 91 
assess the diagnostic value of detection of Aspergillus-specific antibodies using an AGID 92 
assay and an indirect IgG ELISA; and (2) determine if a commercial aspergillin derived from 93 
mycelia of A. fumigatus, Aspergillus niger and Aspergillus flavus can be used to detect serum 94 
antibodies against cryptic Aspergillus spp. in Aspergillus section Fumigati. 95 
 96 
Materials and methods 97 
Signalment data and serum (1-2 mL per cat) were collected prospectively from cats 98 
diagnosed with URTA (group 1), cats with upper respiratory tract (URT) signs not 99 
attributable to aspergillosis (group 2) and from cats without respiratory or fungal disease 100 
(group 3). Samples were collected with informed consent according to the guidelines of the 101 
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Animal Ethics Committee of the University of Sydney (approval number N00/9-2012/5774, 102 
date of approval 22 June 2012). Serum samples were collected at the time of diagnosis and 103 
were stored at -80 °C for batch testing. 104 
 105 
Animals 106 
Group 1: Cats with upper respiratory tract aspergillosis (n = 21) - Inclusion criteria 107 
for cats with URTA were a complete medical history, consistent clinical signs, identification 108 
of fungal hyphae on cytology and/or histopathology of tissue from the sino-nasal cavity or 109 
orbit, and a positive fungal culture (Barrs et al., 2012). Cases with mixed fungal infections 110 
were excluded. Isolates were identified using phenotypic features and comparative sequence 111 
analyses of the internal transcribed spacer (ITS) regions (ITS1-5.8S-ITS2), partial β-tubulin 112 
and/or partial calmodulin genes (Barrs et al., 2013), except for A. fumigatus identification, 113 
where consistent phenotypic features and demonstration of growth at 50 °C was an acceptable 114 
alternative to molecular identification (Barrs and Talbot, 2014). Isolates comprised A. 115 
fumigatus (n = 5), A. flavus (n = 1) and four cryptic species in Aspergillus section Fumigati, 116 
i.e. A. felis (n = 12), Aspergillus thermomutatus (syn. Neosartorya pseudofischeri, n = 1), 117 
Aspergillus lentulus (n = 1) and Aspergillus udagawae (n = 1) (Table 1). 118 
 119 
Cats were classified as having SOA (n = 12) or SNA (n = 9) based on the presence 120 
(SOA) or absence (SNA) of a retrobulbar mass on computed tomography (CT) or magnetic 121 
resonance imaging (MRI) at diagnosis. Sera were tested for antibodies against feline 122 
immunodeficiency virus (FIV) and FeLV antigen (IDEXX SNAP Combo, IDEXX 123 
Laboratories). Medical histories were analysed for the presence of co-morbidities. All cats 124 
were neutered, comprising 11 male neutered (MN) and 10 female neutered (FN) cats, and the 125 
median age was 5 years (range 2-14 years). Breeds comprised domestic crossbred (n = 8), 126 
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Persian (n = 4), Ragdoll (n = 3), Himalayan (n = 2), British shorthair (n = 1), Scottish 127 
shorthair (n = 1), Cornish Rex (n = 1) and Abyssinian (n = 1). 128 
 129 
Group 2: Control cats with other URT disease (n = 25) - Inclusion criteria were: (1) 130 
consistent clinical signs, e.g. sneezing, nasal discharge; (2) absence of fungal hyphae on 131 
cytology or histology of tissue collected from the sino-nasal cavity; and/or (3) serological, 132 
histopathological or endoscopic diagnosis of another URT disease. Standard diagnostic 133 
investigations included latex antigen cryptococcal serology (CALAS, Meridian Bioscience), 134 
upper airway endoscopy, CT examination of the sino-nasal cavity, fungal culture and biopsy. 135 
This group included cats with chronic rhinosinusitis (n = 9), nasal neoplasia (n = 10) 136 
(lymphoma, n = 4; adenocarcinoma, n = 3; squamous cell carcinoma, n = 2; osteosarcoma, n 137 
= 1), upper respiratory cryptococcosis (n = 5) and nasopharyngeal stenosis (n = 1). All cats 138 
were neutered (13 MN, 12 FN). The median age was 11 years (range 4-16 years). Breeds 139 
comprised domestic crossbred (n = 14), Persian (n = 2), Siamese/Oriental (n = 2), Russian 140 
blue (n = 2), Cornish Rex (n = 2), British shorthair (n = 1), Burmilla (n = 1) and Tonkinese (n 141 
= 1). 142 
 143 
Group 3 (i and ii): Control cats without respiratory or fungal disease (n = 84) - 144 
Inclusion criteria for group 3 (i) were healthy cats presenting to the Valentine Charlton Cat 145 
Centre (VCCC) for neutering, vaccination or wellness examination and for group 3 (ii) were 146 
sick cats presenting to the VCCC for non-fungal, non-respiratory illness. Exclusion criteria 147 
for groups 3 (i) and 3 (ii) were any clinical signs within the last 4 weeks or findings at 148 
physical examination suggestive of respiratory disease. This group comprised (i) 36 healthy 149 
cats, including five male entire (M), 11 MN, six female entire (F) and 14 FN, and (ii) 48 cats 150 
presented for non-fungal, non-respiratory illness (one M, 23 MN, 24 FN). Diagnoses in cats 151 
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with non-respiratory disease included hyperthyroidism or post radio-iodine treatment of 152 
hyperthyroidism recheck (n = 12), enteropathy e.g. enteritis, intestinal foreign body (n = 11), 153 
chronic kidney disease (n = 8), allergic skin disease (n = 4), central nervous system disease (n 154 
= 3), diabetes mellitus (n = 2), pancreatitis (n = 2), cholelithiasis (n = 1), chyloabdomen (n = 155 
1), anaemia (n = 1), dog bite wound (n = 1), portosystemic shunt (n = 1) and idiopathic 156 
hypocalcaemia (n = 1). 157 
 158 
Overall, there were 39 males (six M, 33 MN) and 45 females (six F, 39 FN) in group 159 
3; the median age was 8 years (range 0.7-19.5 years). The median age of group 3 (i) cats was 160 
3 years (range 0.7-12 years) and the median age of group 3 (ii) cats was 12 years (range 1-161 
19.5 years). Breeds comprised domestic crossbred (n = 67), Burmese (n = 3), Ragdoll (n = 3), 162 
Devon Rex (n = 2) and one each of Cornish Rex, Abyssinian, Siamese, Birman, Bengal, 163 
Persian, Russian blue, British shorthair and Singapura. 164 
 165 
Agar gel double immunodiffusion 166 
Detection of precipitating anti-Aspergillus antibodies by AGID (Ouchterlony method) 167 
was performed using a commercially available test-kit (Fungal Immunodiffusion Kit, 168 
Meridian Bioscience) comprising agar immunodiffusion plates, an aspergillin derived from 169 
the mycelial phase of cultures of A. fumigatus, A. niger and A. flavus with a protein content of 170 
1486 μg/mL (Aspergillus Immunodiffusion Antigen reference number 100501, Meridian 171 
Bioscience) and goat anti-Aspergillus immunodiffusion control serum (reference number 172 
100901, Meridian Bioscience). Testing was performed in accordance with the manufacturer’s 173 
instructions using 20 µL each of control sera, test serum and aspergillin. All samples were 174 
tested in duplicate. Gels were examined for the presence of precipitin bands of identity or 175 
partial identity after 24 h and again after an additional 48 h incubation (final reading) in a 176 
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humidified chamber at room temperature. Visualisation of precipitin bands was facilitated by 177 
directing a high intensity light beam at a 45° angle below the plate, with the latter held against 178 
a black background. 179 
 180 
Aspergillus-specific IgG quantification by indirect ELISA 181 
An indirect ELISA for detection and quantification of Aspergillus-specific IgG 182 
antibodies in canine sera using the same aspergillin as for the AGID was modified for use in 183 
cats (Billen et al., 2009). Binding activity using polyvinylchloride or polystyrene 96 well 184 
plates was assessed as similar. Two commercially available secondary antibodies, rabbit anti-185 
cat IgG (H&L), ALP conjugated, were evaluated (SAB 37008-1, Sigma; AS10 1479, 186 
Agrisera). 187 
 188 
The assay was optimised by performing checkerboard titrations to determine the 189 
optimal dilutions of antigen, cat serum and secondary antibody. Inter- and intra-plate 190 
coefficients of variation were calculated by running 40 repeats of the positive control sample 191 
(pooled positive control sera from seven cats with confirmed aspergillosis and a positive 192 
AGID result) on four separate plates with 10 repeats on each plate. Test samples were run in 193 
duplicate and each plate contained a duplicate positive control, a negative control (pooled 194 
negative control sera from 15 healthy controls with a negative AGID result), and a blank 195 
(phosphate buffered saline, PBS, plus 0.05% Tween 20, Sigma; PBS-T). Sera were titrated in 196 
doubling dilutions from 1:800 to 1:102,400. 197 
 198 
Ninety-six well enzyme immunoassay (EIA)/radioimmunoassay (RIA) polystyrene 199 
plates (Costar 3590, Corning) were coated with 75 µL aspergillin (2.5 µg protein/mL) and 200 
incubated at 4 °C overnight. Plates were blocked with 75 µL 1% w/v polyvinylpyrrolidone 201 
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(Sigma) in PBS for 1 h at room temperature. Fifty microlitres of patient sera was diluted in 202 
5% non-fat milk in PBS-T, titrated on plates in doubling dilutions from 1:800 to 1:102,400 203 
and incubated for 2 h at 37 °C. Fifty microlitres of 1:8000 rabbit anti-cat IgG (H&L), ALP 204 
conjugated, antibody solution (SAB 37008-1, Sigma) diluted in PBS-T was added to each 205 
well and incubated for 1 h at 37 °C. Next, 200 µL SigmaFAST p-nitrophenyl alkaline 206 
phosphate substrate (Sigma) was added to each well, incubated in the dark for 45 min then 207 
stopped with 50 µL of 3 M NaOH. Optical density (OD) was determined using a plate reader 208 
with a 405 nm and 492 nm wavelength filter (Benchmark Plus microplate spectrophotometer, 209 
Bio-Rad Laboratories). All incubations were performed in a humidified chamber and wells 210 
were washed three times between incubations with 150 µL PBS. 211 
 212 
Statistical analysis 213 
The mean age of cats was compared between groups using a general linear model. Sex 214 
proportions were compared using a χ2 test. For the purpose of statistical analyses, breeds were 215 
grouped into brachycephalic (Persian/Persian-cross, Himalayan, Ragdoll, Birman, Burmilla, 216 
British/Scottish shorthair) and non-brachycephalic (Domestic short/longhair, Cornish/Devon 217 
Rex, Bengal, Russian blue, Oriental, Siamese, Tonkinese, Singapura). Proportions of cats in 218 
brachycephalic and non-brachycephalic groups, and proportions of positive test results for 219 
cats infected with A. fumigatus versus cryptic species were compared using Fisher’s exact 220 
test. 221 
 222 
Values for median ELISA units (EU) in group 1 were compared between AGID 223 
positive and AGID negative cats, and between cats with A. fumigatus infections and those 224 
infected with cryptic species, using non-parametric Mann and Whitney U tests. For analysis 225 
of ELISA data, the geometric mean optical OD for each set of duplicate serum samples was 226 
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calculated and log10 OD values were plotted against log10 serum dilutions for positive control 227 
and test sera in Microsoft Excel. The curves generated were compared for parallelism and IgG 228 
concentrations were expressed as EU/mL, with the positive control serum standard having a 229 
concentration of 100 EU/mL (Billen et al., 2009). Serum samples with fewer than three 230 
dilution points within the linear range of the standard, and thus considered to have antibody 231 
concentrations below the detectable limit of the ELISA (<2.5 EU/mL), were assigned a value 232 
of 0 EU/mL. An association between age and IgG quantification in EU/mL in controls was 233 
investigated using simple linear regression. 234 
 235 
Cut-off values were established by determination of the mean plus three SD of the IgG 236 
concentration of the controls and by receiver operating characteristic (ROC) analysis. ROC 237 
analysis was conducted by fitting a logistic regression model of log EU values on the binary 238 
outcome (1 or 0) created by specifying the URTA group as 1 and the control group as 0 239 
(Dohoo et al., 2009). ROC analyses were conducted for group 2, group 3 and both groups 240 
combined. The optimal cut-off value for each analysis was determined using Youden’s J 241 
index. Se and specificity (Sp) at the determined cut-off values were reported as described by 242 
de Silva et al. (2013). Analyses were conducted using SAS 2002-2003 (SAS Institute/IBM). 243 
A 5% level of significance was used for all statistical tests. 244 
 245 
Results 246 
Cats 247 
In group 1, one cat (cat 5) was determined to be FIV-infected on the basis of a positive 248 
FIV antibody response and no history of FIV vaccination; the other 20 cats in group 1 tested 249 
negative for FIV and FeLV (Table 1). The mean age of cats in group 1 (6.3 years) was 250 
significantly different from that of cats in group 2 (9.8 years; P <0.01) and group 3 (i) (4.0 251 
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years, P <0.01), but not from the combined group 3 (i and ii: 8.2 years, P = 0.1) or a 252 
combined control group (groups 2 + 3: 8.7 years; P = 0.06). There were no significant 253 
differences in sex between groups (P = 0.9). The proportions of brachycephalic breeds were 254 
significantly different between groups 1 and 2, and between groups 1 and 3, but not between 255 
groups 2 and 3 (P = 0.2); 11/21 (52%) group 1 cats were brachycephalic compared to 4/25 256 
(16%) group 2 cats (P <0.05) and 4/84 (5%) group 3 cats (P < 0.01). 257 
 258 
Agar gel double immunodiffusion 259 
Nine of 21 sera (43%) from cats with URTA (group 1) were positive in the AGID 260 
(Table 1). Sera from all 25 cats in group 2 and 84 cats in group 3 tested negative. The Se, Sp, 261 
positive predictive value (PPV) and negative predictive value (NPV) of AGID for the 262 
diagnosis of URTA are given in Table 2. Of the nine cats with positive AGID results, one was 263 
infected with A. fumigatus and eight were infected with cryptic species, including A. felis (n = 264 
7) and A. udagawae (n = 1) (Table 1). There was no association between test result (positive 265 
or negative) and infecting species (A. fumigatus versus cryptic species; P = 0.3). 266 
 267 
IgG ELISA 268 
The intra- and inter-plate coefficients of variation of the ELISA were 7.4% and 9.3%, 269 
respectively. Sera from cats that did not generate a dilution curve with a minimum of three 270 
dilution points within the range of the standard serum were assigned an Aspergillus-specific 271 
IgG concentration of 0 EU/mL (20/25 group 2 cats and 74/84 group 3 cats). Cut-off values 272 
calculated using the mean plus three SD of the IgG concentration and using ROC analysis 273 
were similar, yielding results of 5.6 and 6.0 EU/mL, respectively, regardless of the control 274 
group used. Se and Sp were optimal at a cut-off value of 6 EU/mL (Table 3); at this cut-off 275 
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value, the Se was 95.2%, the Se was 92.0%, the PPV was 90.9% (95% confidence interval, 276 
CI, 70.8-98.6%) and the NPV was 95.5% (95% CI 78.8-99.3%). 277 
 278 
Using the calculated cut-off value of 6.0 EU/mL, a positive IgG ELISA result was 279 
obtained for sera from 20/21 (95.2%) cats with URTA (range 6.3-797.9 EU/mL) (Table 1), 280 
from 2/25 (8.0%) cats, both with cryptococcal rhinitis, in group 2 (8.7 and 80.7 EU/mL) and 281 
6/84 (7.1%) cats in group 3 (7.3-8.9 EU/mL) (Fig. 1). The median Aspergillus-specific IgG 282 
concentration in cats with URTA (group 1) was 55.7 EU/mL. Among cats with URTA, there 283 
was no significant difference in Aspergillus-specific IgG concentrations in cases with A. 284 
fumigatus infection (median 67 EU/mL; n = 5) and cases with infection by cryptic species 285 
(other members of the A. fumigatus complex; median 56.6 EU/mL; n = 15; P = 0.1). There 286 
was no association between test result (positive or negative) and infecting species (A. 287 
fumigatus versus cryptic species; P = 0.3). The median Aspergillus-specific IgG 288 
concentrations of cats with positive AGID results was 78.3 EU/mL, compared to 31.95 289 
EU/mL for cats with negative AGID results (P = 0.2). There was no significant effect of age 290 
on EU values of combined groups 2 and 3 (P = 0.05) or group 3 alone (P = 0.2). 291 
 292 
Discussion 293 
In this study, we demonstrated that antibodies against four cryptic species of 294 
Aspergillus (A. felis, A. udagawae, A. lentulus and A. thermomutatus) can be detected in feline 295 
serum with assays utilising a commercial aspergillin derived from A. fumigatus, A. niger and 296 
A. flavus. Although this result was not unexpected given the close phylogenetic relationship 297 
of these cryptic species to A. fumigatus (Barrs et al., 2013; Novakova et al., 2014), it is 298 
important to demonstrate this cross reactivity, given the high frequency of infections with 299 
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such cryptic species in cats. A. felis and A. udagawae are the two most commonly reported 300 
species of Aspergillus to cause SOA in cats (Kano et al., 2008, 2013; Barrs et al., 2013, 2014). 301 
 302 
There was a marked difference in the Se of the AGID and the IgG ELISA for 303 
detection of Aspergillus-specific antibodies, while the Sp for both assays was high. In contrast 304 
to the IgG ELISA, which detects one class of antibody, immunodiffusion assays detect 305 
precipitins (Crowle, 1973). In AGID assays, optimal diffusion depends on many factors 306 
including sufficiently large antigen (Ag) and antibody (Ab) reservoirs to maintain infinite 307 
pools of reactants (Kunkel, 1988). Since a commercial test kit was utilised in the present 308 
study, optimisation of the assay was not performed. The same commercial AGID has been 309 
evaluated for diagnosis of canine SNA, which is caused by A. fumigatus in >95% of cases, 310 
with reported Se of 57-67% (Pomrantz et al., 2007; Pomrantz and Johnson, 2010; Barrs and 311 
Talbot, 2014). Another commercial AGID (Immuno-Mycologics) had a Se of 31% for 312 
diagnosis of canine SNA (Peeters and Clercx, 2007). The highest reported Se of 76.5% using 313 
an AGID for diagnosis of canine SNA utilised a customised Ouchterlony method (Billen et 314 
al., 2009). 315 
 316 
The IgG ELISA had high Se and Sp overall, indicating that the production of 317 
Aspergillus-specific IgG is a reliable indicator of URTA. Depending on the cut-off value and 318 
control group used, the Se of the assay was 91-100% and the Sp was 92-100%. Cases with 319 
URT diseases other than aspergillosis (group 2) represent the most relevant control group in a 320 
clinical situation. Of interest, both cats with false positive IgG results in group 2 had 321 
cryptococcosis. The high antibody titre detected in one cat with sino-orbital cryptococcosis 322 
(80.7 EU/mL) was repeatable. The cat had a latex cryptococcal antigen titre of 1024 323 
(Meridian, CALAS 2010) and Cryptococcus gattii was cultured from the nasal cavity. On CT 324 
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there was a retrobulbar mass arising from the nasal cavity, but yeasts were not seen on 325 
cytology of fine-needle aspirate biopsies. The cat was treated with itraconazole for one year 326 
until the LCAT decreased to zero and clinical signs resolved. Possible explanations for the 327 
high antibody titre are a false positive disease result or a true result due to co-infection with 328 
Aspergillus spp., which is possible, but unlikely. Concurrent pulmonary cryptococcosis and 329 
aspergillosis has been documented rarely in humans (Lin et al., 2006; Enoki et al., 2012). 330 
 331 
The high frequency of Aspergillus-specific IgG and the low frequency of retroviral 332 
infection by serology in group 1 cats (0% for FeLV; 4.7% for FIV) provides further evidence 333 
that cats with URTA are not systemically immunocompromised (Whitney et al., 2013). Other 334 
causes of immunosuppression documented in cats with DIA, such as feline panleukopenia, 335 
feline infectious peritonitis or prolonged corticosteroid therapy (Ossent, 1987), were not 336 
evident amongst cats with URTA tested in the present study. However, local disease that may 337 
have predisposed to sino-nasal cavity fungal colonisation was identified in two cats; one cat 338 
with A. fumigatus infection had concurrent nasal adenocarcinoma (cat 17) and one cat with A. 339 
flavus infection had plant material removed from the nasal cavity during endoscopy (cat 20) 340 
(Table 1). To further our understanding of the immunopathogenesis of this disease, additional 341 
studies of the humoral response to URTA, including quantification of IgM and IgA in 342 
affected cats, are warranted. 343 
 344 
Our finding that pure bred cats of brachycephalic conformation were significantly 345 
more likely to develop URTA confirms a predisposition which, until now, has only been 346 
suspected (Tomsa et al., 2003; Whitney et al., 2005; Barrs et al., 2012). Impaired sinus 347 
aeration and drainage associated with brachycephalic skull conformation that favours fungal 348 
colonisation has been proposed as a mechanism for this breed association (Tomsa et al., 349 
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2003). A heritable disorder of innate immunity has also been proposed (Barrs and Talbot, 350 
2014). Chronic invasive granulomatous fungal rhinosinusitis of humans, similar to feline 351 
SOA, occurs in immunocompetent people in the Indian subcontinent, especially those 352 
working in agriculture and construction (Thompson and Patterson, 2012). In contrast to feline 353 
SOA, the aetiological agent is usually A. flavus. A. flavus is an uncommon cause of URTA in 354 
cats and only a single case has been identified previously (Malik et al., 2004). 355 
 356 
Using a cut-off value of 5 EU/mL to optimise the IgG ELISA for Se makes this assay 357 
an ideal screening test for URTA in cats with consistent clinical signs; positive results should 358 
be corroborated with additional tests, such as fungal culture. Assay Sp was not 100% even at 359 
the cut-off value optimised for Sp (9 EU/mL) in group 2 cats, the most clinically relevant 360 
control group. Therefore, serology should not be relied upon as the sole diagnostic test for 361 
URTA. 362 
 363 
Conclusions 364 
Detection of Aspergillus-specific IgG by AGID and ELISA was highly specific for the 365 
diagnosis of aspergillosis in cats. The Se of IgG detection by ELISA was high, whereas the Se 366 
of detection using AGID was low. Depending on the cut-off value used, the ELISA has good 367 
discriminatory power to distinguish between presumed environmental exposure, which 368 
increases with age, and that induced by colonisation and infection. This study provides further 369 
evidence that feline URTA affects systemically immunocompetent individuals. 370 
 371 
Conflict of interest statement 372 
None of the authors has any other financial or personal relationships that could 373 
inappropriately influence or bias the content of the paper. 374 
Page 15 of 23
16 
 
 375 
Acknowledgements 376 
This study was funded by an Australian Companion Animal Health Foundation grant 377 
(015/2013). The sponsors were not involved in any aspect of the study or in the decision to 378 
publish this manuscript. The authors thank many colleagues for contributions of clinical 379 
samples for this study. 380 
 381 
References 382 
Barrs, V.R., Halliday, C., Martin, P., Wilson, B., Krockenberger, M., Gunew, M., Bennett, S., 383 
Koehlmeyer, E., Thompson, A., Fliegner, et al., 2012. Sinonasal and sino-orbital 384 
aspergillosis in 23 cats: Aetiology, clinicopathological features and treatment 385 
outcomes. The Veterinary Journal 191, 58-64. 386 
 387 
Barrs, V.R., van Doorn, T., Houbraken, J., Kidd, S.E., Martin, P., Pinheiro, M.D., Richardson, 388 
M., Varga, J., Samson, R.A., 2013. Aspergillus felis sp. nov., an emerging agent of 389 
invasive aspergillosis in humans, cats and dogs. PLoS One 8, e64781. 390 
 391 
Barrs, V.R., Beatty, J.A., Dhand, N., Talbot, J., Bell, E., Abraham, L.A., Chapman, P., 392 
Bennett, S., van Doorn, T., Makara, M., 2014. Computed tomographic features of 393 
feline sino-nasal and sino-orbital aspergillosis. The Veterinary Journal 201, 215-222. 394 
 395 
Barrs, V.R., Talbot, J., 2014. Feline aspergillosis. Veterinary Clinics of North America: Small 396 
Animal Practice 44, 51-73. 397 
 398 
Billen, F., Peeters, D., Peters, I.R., Helps, C.R., Huynen, P., De Mol, P., Massart, L., Day, 399 
M.J., Clercx, C., 2009. Comparison of the value of measurement of serum 400 
galactomannan and Aspergillus-specific antibodies in the diagnosis of canine sino-401 
nasal aspergillosis. Veterinary Microbiology 133, 358-365. 402 
 403 
Crowle, A.J., 1973. Immunodiffusion, 2nd Edn. Academic Press, New York, NY, USA, pp 1-404 
78. 405 
 406 
Day, M.J., Eger, C.E., Shaw, S.E., Penhale, W.J., 1985. Immunological study of systemic 407 
aspergillosis in German shepherd dogs. Veterinary Immunology Immunopathology 9, 408 
335-347. 409 
 410 
de Silva, K., Purdie, A.C., Kawaji, S., Dhand, N.K., Whittington, R.J., 2013. Can early host 411 
responses to mycobacterial infection predict eventual disease outcomes? Preventive 412 
Veterinary Medicine 112, 203-212. 413 
 414 
Page 16 of 23
17 
 
Dohoo, I., Martin, W., Stryhn, H., 2009. Veterinary Epidemiologic Research, 2nd Edn. VER, 415 
Charlottetown, Prince Edward Island, Canada, 865 pp. 416 
 417 
Enoki, E., Maenishi, O., Chikugo, T., Ito, A., Kimura, M., 2012. Coinfection of Aspergillus 418 
and Cryptococcus in post-tuberculosis pulmonary cavity. Pathology International 62, 419 
574-576. 420 
 421 
Garcia, R.S., Wheat, L.J., Cook, A.K., Kirsch, E.J., Sykes, J.E., 2012. Sensitivity and 422 
specificity of a blood and urine galactomannan antigen assay for diagnosis of systemic 423 
aspergillosis in dogs. Journal of Veterinary Internal Medicine 26, 911-919. 424 
 425 
Goodall, S.A., Lane, J.G., Warnock, D.W., 1984. The diagnosis and treatment of a case of 426 
nasal aspergillosis in a cat. Journal of Small Animal Practice 25, 627-633. 427 
 428 
Guitard, J., Sendid, B., Thorez, S., Gits, M., Hennequin, C., 2012. Evaluation of a 429 
recombinant antigen-based enzyme immunoassay for the diagnosis of noninvasive 430 
aspergillosis. Journal of Clinical Microbiology 50, 762-765. 431 
 432 
Hope, W.W., Walsh, T.J., Denning, D.W., 2005. Laboratory diagnosis of invasive 433 
aspergillosis. Lancet Infectious Diseases 5, 609-622. 434 
 435 
Kano, R., Itamoto, K., Okuda, M., Inokuma, H., Hasegawa, A., Balajee, S.A., 2008. Isolation 436 
of Aspergillus udagawae from a fatal case of feline orbital aspergillosis. Mycoses 51, 437 
360-361. 438 
 439 
Kano, R., Shibahashi, A., Fujino, Y., Sakai, H., Mori, T., Tsujimoto, H., Yanai, T., Hasegawa, 440 
A., 2013. Two cases of feline orbital aspergillosis due to A. udagawae and A. 441 
virdinutans. Journal of Veterinary Medical Science 75, 7-10. 442 
 443 
Kitasato, Y., Tao, Y., Hoshino, T., Tachibana, K., Inoshima, N., Yoshida, M., Takata, S., 444 
Okabayashi, K., Kawasaki, M., Iwanaga, T., et al., 2009. Comparison of Aspergillus 445 
galactomannan antigen testing with a new cut-off index and Aspergillus precipitating 446 
antibody testing for the diagnosis of chronic pulmonary aspergillosis. Respirology 14, 447 
701-708. 448 
 449 
Kunkel, J.G. 1988. Analytical immunologic techniques. In: Gilbert, L.I., Miller, T.A. (Eds) 450 
Immunological Techniques in Insect Biology. Springer, New York, NY, USA, pp. 1-451 
41. 452 
 453 
Lin, C.M., Tsai, Y.H., Huang, C.C., Lee, C.H., Chiang, P.C., Huang, S.F., Liu, H.P., 2006. 454 
Invasive pulmonary aspergillosis and pulmonary cryptococcosis really coexist in 455 
immunocompromised host. Journal of Infection 53, e55-e58. 456 
 457 
Maertens, J., Verhaegen, J., Demuynck, H., Brock, P., Verhoef, G., Vandenberghe, P., van 458 
Eldere, J., Verbist, L., Boogaerts, M., 1999. Autopsy-controlled prospective 459 
evaluation of serial screening for circulating galactomannan by a sandwich enzyme-460 
linked immunosorbent assay for hematological patients at risk for invasive 461 
aspergillosis. Journal of Clinical Microbiology 37, 3223-3228. 462 
 463 
Page 17 of 23
18 
 
Malik, R., Vogelnest, L., O'Brien, C.R., White, J., Hawke, C., Wigney, D.I., Martin, P., 464 
Norris, J.M., 2004. Infections and some other conditions affecting the skin and 465 
subcutis of the naso-ocular region of cats - clinical experience 1987-2003. Journal of 466 
Feline Medicine and Surgery 6, 383-390. 467 
 468 
Novakova, A., Hubka, V., Dudova, Z., Matsuzawa, T., Kubatova, A., Yaguchi, T., Kolarik, 469 
M., 2014. New species in Aspergillus section Fumigati from reclamation sites in 470 
Wyoming (U.S.A.) and revision of A. viridinutans complex. Fungal Diversity, 64, 471 
253-274. 472 
 473 
Ohba, H., Miwa, S., Shirai, M., Kanai, M., Eifuku, T., Suda, T., Hayakawa, H., Chida, K., 474 
2012. Clinical characteristics and prognosis of chronic pulmonary aspergillosis. 475 
Respiratory Medicine 106, 724-729. 476 
 477 
Ossent, P., 1987. Systemic aspergillosis and mucormycosis in 23 cats. Veterinary Record 120, 478 
330-333. 479 
 480 
Peeters, D., Clercx, C., 2007. Update on canine sinonasal aspergillosis. Veterinary Clinics of 481 
North America: Small Animal Practice 37, 901-916. 482 
 483 
Pomrantz, J.S., Johnson, L.R., Nelson, R.W., Wisner, E.R., 2007. Comparison of serologic 484 
evaluation via agar gel immunodiffusion and fungal culture of tissue for diagnosis of 485 
nasal aspergillosis in dogs. Journal of the American Veterinary Medical Association 486 
230, 1319-1323. 487 
 488 
Pomrantz, J.S., Johnson, L.R., 2010. Repeated rhinoscopic and serologic assessment of the 489 
effectiveness of intranasally administered clotrimazole for the treatment of nasal 490 
aspergillosis in dogs. Journal of the American Veterinary Medical Association 236, 491 
757-762. 492 
 493 
Schultz, R.M., Johnson, E.G., Wisner, E.R., Brown, N.A., Byrne, B.A., Sykes, J.E., 2008. 494 
Clinicopathologic and diagnostic imaging characteristics of systemic aspergillosis in 495 
30 dogs. Journal of Veterinary Internal Medicine 22, 851-859. 496 
 497 
Talbot, J., Johnson, L.R., Martin, P., Beatty, J.A., Sutton, D.A., Billen, F., Halliday, C., 498 
Gibson, J.S., Kidd, S.E., Steiner, J., et al., 2014. What causes canine sino-nasal 499 
aspergillosis? A molecular approach to species identification. The Veterinary Journal 500 
200, 17-21. 501 
 502 
Thompson, G.R., Patterson, T.F., 2012. Fungal disease of the nose and paranasal sinuses. 503 
Journal of Allergy and Clinical Immunology 129, 321-326. 504 
 505 
Tomsa, K., Glaus, T.M., Zimmer, C., Greene, C.E., 2003. Fungal rhinitis and sinusitis in three 506 
cats. Journal of the American Veterinary Medical Association 222, 1365, 1380-1384. 507 
 508 
Whitney, B.L., Broussard, J., Stefanacci, J.D., 2005. Four cats with fungal rhinitis. Journal of 509 
Feline Medicine and Surgery 7, 53-58. 510 
 511 
Page 18 of 23
19 
 
Whitney, J., Beatty, J.A., Dhand, N., Briscoe, K., Barrs, V.R., 2013. Evaluation of serum 512 
galactomannan detection for the diagnosis of feline upper respiratory tract 513 
aspergillosis. Veterinary Microbiology 162, 180-185. 514 
Figure legend 515 
 516 
Fig. 1. ELISA units/mL for 21 group 1 sera (cats with aspergillosis; black circles), 25 group 2 517 
sera (control cats with other upper respiratory tract disease; black stars) and 84 group 3 sera 518 
(control cats, either healthy or sick with non-respiratory disease; grey circles). Lines represent 519 
means ± standard deviations. 520 
521 
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Table 1 522 
Fungal species and serology results for group 1 cats with upper respiratory tract aspergillosis. 523 
 524 
Cat 
a 
Age (years) Sex
 
Breed Form
 
Fungal species 
b 
AGID ELISA (units/mL) 
1 2  MN Ragdoll SNA A. thermomutatus 
(N. pseudofischeri) 
- 35.7 
2 2  FN DSH SOA A. felis + 273.1 
3 5  FN Cornish Rex SOA A. felis - 797.9 
4 13  MN DSH SNA A. felis - 5 
5 14  FN Persian cross SNA A. lentulus - 38 
6 3  MN DSH SOA A. felis - 26 
7 8  FN Persian SOA A. felis + 215.5 
8 2  MN British shorthair SOA A. felis + 110.7 
9 7  MN Persian SNA A. fumigatus - 28.2 
10 2  MN Himalayan SOA A. felis + 35.8 
11 8  MN DLH SOA A. udagawae + 55.7 
12 8  FN Scottish shorthair SNA A. fumigatus + 56.6 
13 5  FN DSH SOA A. felis + 154.9 
14 4  MN  Ragdoll SOA A. felis + 49.7 
15 3  FN Himalayan SOA A. felis + 78.3 
16 2  FN DSH SOA A. felis - 295.1 
17
 
14 FN Abyssinian SNA A. fumigatus - 16.1 
18 3  MN Ragdoll SOA A. felis - 288.42 
19
 
14  FN Persian SNA A. fumigatus - 24.6 
20 4  MN DSH SNA A. flavus - 6.3 
21 7  MN DSH SNA A. fumigatus - 82.4 
 525 
AGID, agar gel immunodiffusion; DSH, domestic shorthair; DLH, domestic longhair; FN, female neutered; MN, 526 
male neutered; SNA, sino-nasal aspergillosis; SOA, sino-orbital aspergillosis. 527 
a
 Aspergillus spp.; A. thermomutatus syn. Neosartorya pseudofischeri; country of origin was Australia except 528 
cats 17 (USA), 19 (UK) and 21 (Belgium). 529 
b
 Signalment of cat and molecular identity of isolates for cats 1-15 has been reported elsewhere (Barrs et al., 530 
2013, 2014). 531 
532 
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Table 2 533 
Diagnostic accuracy of agar-gel double immunodiffusion in 21 cats with sino-nasal and sino-orbital 534 
aspergillosis. 535 
 536 
 Control group 2
 a
 
(n = 25) 
Control group 3
 b
 
(n = 84) 
Control groups 2 and 3 
(n = 109) 
% 95% CI % 95% CI
 
% 95% CI 
Se
 
42.9 21.9-66.0 42.9 21.9-66.0 42.9 21.9-66.0 
Sp
 
100.0 86.2-100.0 100.0 95.7-100.0 100.0 96.6-100.0 
PPV
 
100.0 66.2-100.0 100.0 66.2-100.0 100.0 66.2-100.0 
NPV 87.5 50.2-100.0 97.7 79.2-93.4 90.1 83.3-94.8 
 537 
CI, confidence interval; Se, sensitivity; Sp, specificity; PPV, positive predictive value; NPV, negative predictive 538 
value. 539 
a
 Cats with other upper respiratory tract diseases (excluding aspergillosis). 540 
b 
Healthy controls (n = 36) and sick cats (n = 48) with non-fungal, non-respiratory illness. 541 
542 
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Table 3 543 
Performance of IgG ELISA for detection of Aspergillus-specific antibodies at different cut-off values. 544 
 545 
   Cut-off value (EU/mL) 
   5 6 9 
Controls 
 
AUC 95% CI for AUC Se
 
Sp
 
Se Sp Se Sp 
Group 2 0.97  0.92-1.00 100.0% 
(21/21) 
92.0% 
(23/25) 
95.2% 
(20/21) 
92.0% 
(23/25) 
90.5% 
(19/21) 
96.0% 
(24/25) 
Group 3 0.97 0.98-1.00 100.0% 
(21/21) 
91.7% 
(77/84) 
95.2% 
(20/21) 
92.9% 
(78/84) 
90.5% 
(19/21) 
100.0% 
(84/84) 
Group 2 and 3 0.99 0.97-1.00 100.0% 
(21/21) 
91.7% 
(100/109) 
95.2% 
(20/21) 
92.7% 
(101/109) 
90.5% 
(19/21) 
99.1% 
(108/109) 
 546 
CI, confidence interval; AUC, area under curve; SE, sensitivity; SP, specificity. 547 
548 
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